Upgrade to SI Premium - Free Trial

Teleflex (TFX) Tops Q1 EPS by 45c, Revenues Beat; Raises FY21 EPS Outlook

April 29, 2021 6:38 AM

Teleflex (NYSE: TFX) reported Q1 EPS of $2.87, $0.45 better than the analyst estimate of $2.42. Revenue for the quarter came in at $633.9 million versus the consensus estimate of $626.25 million.

GUIDANCE:

Teleflex sees FY2021 EPS of $12.50-$12.70, versus the consensus of $12.63.

The Company raised its full year 2021 GAAP revenue growth estimates from a range of between 10.0% and 11.5% over 2020, to a range of between 10.50% and 11.75% over 2020, reflecting our estimate of an approximately 2% favorable impact of foreign currency exchange rate fluctuations. On a constant currency basis, the Company raised its full year 2021 revenue growth estimates from a range of between 8.0% and 9.5% over 2020, to a range of between 8.50% and 9.75% over 2020. The Company reaffirmed its full year 2021 revenue growth estimate of 30% associated with its Interventional Urology business.

The Company lowered its full year 2021 GAAP diluted earnings per share from continuing operations from a range of between $8.15 and $8.25 to a range of between $8.00 and $8.10. The Company raised its full year 2021 adjusted diluted earnings per share from continuing operations from a range of between $12.50 and $12.70 to a range of between $12.65 and $12.85.

For earnings history and earnings-related data on Teleflex (TFX) click here.

Categories

Corporate News Earnings Guidance Hot Guidance Management Comments

Next Articles